CFDE Data Portal | Search PRMT5

	Label	Description
	e9b7d287-40b3-44b6-9a10-be28cf2347f0 Project (Entity type)	THE CELL NUCLEUS UNDER STRESS
	GSE246325 PRMT5 inhibition 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	PRMT5 Gene (Entity type)	ENSG00000100462 - protein arginine methyltransferase 5
	GSE246325 PRMT5 inhibition 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 1 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

e9b7d287-40b3-44b6-9a10-be28cf2347f0

THE CELL NUCLEUS UNDER STRESS

GSE246325 PRMT5 inhibition 0 v 4 human up

A Gene Set from LINCS

PRMT5

ENSG00000100462 - protein arginine methyltransferase 5

GSE246325 PRMT5 inhibition 0 v 4 human dn

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 1 v 5 human dn

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 1 v 5 human up

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 1 v 4 human dn

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 0 v 5 human up

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 0 v 5 human dn

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 1 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.